Paper Details

  1. Home
  2. Paper Details

Systematic review of pharmacological treatments in fragile X syndrome.

Author: BallesterosJavier, RuedaJose-Ramon, TejadaMaria-Isabel

Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability. People with FXS often experience attention problems, autism, and speech and behavior challenges. Various medications have been proposed to treat these issues.
Paper Details　
Original Abstract of the Article :
Fragile X syndrome (FXS) is considered the most common cause of inherited mental retardation. Affected people have mental impairment that can include Attention Deficit and/or Hyperactivity Disorder (ADHD), autism disorder, and speech and behavioural disorders. Several pharmacological interventions h...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770029/

データ提供：米国国立医学図書館（NLM）

Fragile X Syndrome: A Look into Pharmacological Treatments

The realm of [pharmacology] is constantly searching for novel treatments for [fragile X syndrome (FXS)]. FXS, a common cause of [inherited mental retardation], presents a unique challenge due to its diverse range of symptoms. This study delves into the landscape of pharmacological interventions that target these impairments, including [Attention Deficit and/or Hyperactivity Disorder (ADHD)], [autism disorder], and [speech and behavioural disorders]. The authors meticulously reviewed available studies to shed light on the effectiveness of various medications in managing FXS. Their findings provide valuable insights for clinicians seeking to optimize treatment strategies for individuals with this complex condition.

The Promise of Tailored Treatments

This research underscores the need for personalized treatment approaches for FXS. The authors highlight the importance of considering the specific symptoms exhibited by each individual to select the most appropriate pharmacological intervention. This approach holds great promise for improving outcomes and enhancing the quality of life for individuals with FXS.

Navigating the Desert of FXS: A Guide for Patients

While [pharmacological treatments] can offer significant benefits for individuals with FXS, it is crucial to consult with healthcare professionals to determine the optimal course of action. As a fellow traveler in the vast desert of medical knowledge, I encourage you to embrace the opportunity to discuss your individual needs and concerns with your doctor. By working together, we can navigate this challenging terrain and find solutions that bring comfort and hope.

Dr.Camel's Conclusion

This systematic review is like a compass guiding us through the complexities of FXS. It reveals the diverse landscape of pharmacological treatments available, highlighting the importance of tailored approaches for individual needs. As we continue to explore the vast desert of FXS, this research provides invaluable knowledge to aid our journey.

Date :
  1. Date Completed 2009-12-09
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

19822023

DOI: Digital Object Identifier

PMC2770029

Related Literature

Article Analysis
・Effective treatment of fragile x syndrome
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.